{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-23-095718","form_type":"8-K","ticker":"RFL","cik":"0001713863","company_name":"Rafael Holdings, Inc.","filed_at":"2023-12-14T23:59:59+00:00","discovered_at":"2026-05-14T18:03:30.152574+00:00","generated_at":"2026-06-07T12:54:02.803032+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Rafael Holdings Q1 fiscal 2024 net loss narrows to $3.8M from $5.2M YoY","bullets":["Net loss from continuing operations of $3.8M ($0.15/share) vs $5.2M ($0.22/share) a year ago.","Cash, cash equivalents and marketable securities of $72.1M as of Oct 31, 2023.","R&D expenses fell to $0.5M from $2.1M, driven by winding down early-stage programs.","G&A expenses decreased to $2.0M from $3.1M due to lower stock-based compensation and payroll.","CEO says company advancing portfolio and seeking strategic investments; continues supporting Cyclo Therapeutics (CYTH)."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-23-095718","json":"https://secwatch.observer/filing/0001213900-23-095718.json","markdown":"https://secwatch.observer/filing/0001213900-23-095718.md","text":"https://secwatch.observer/filing/0001213900-23-095718.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1713863/000121390023095718/0001213900-23-095718-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1713863/000121390023095718/ea190031-8k_rafael.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-07T12:54:02.803032+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"e7f57e6769d38db91ba320501d030ded53efbe66","claim":"Rafael Holdings, Inc. reported first quarter of fiscal 2024 - the three months ended October 31, 2023 results: net income net loss from continuing operations of $3.8 million, or $0.15 per share, EPS $0.15 per share.","evidence_excerpt":"Rafael Holdings Reports First Quarter Fiscal 2024 Financial Results","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1713863/000121390023095718/0001213900-23-095718-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"first quarter of fiscal 2024 - the three months ended October 31, 2023"},{"label":"Net income","value":"net loss from continuing operations of $3.8 million, or $0.15 per share"},{"label":"EPS","value":"$0.15 per share"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}